India Bioequivalence Studies Market Size & Outlook
Related Markets
India bioequivalence studies market highlights
- The India bioequivalence studies market generated a revenue of USD 23.3 million in 2023 and is expected to reach USD 42.6 million by 2030.
- The India market is expected to grow at a CAGR of 9% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating molecule type in 2023.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Bioequivalence studies market data book summary
| Market revenue in 2023 | USD 23.3 million |
| Market revenue in 2030 | USD 42.6 million |
| Growth rate | 9% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Drug Development, Kymos Pharma Services, Spectris PLC |
Other key industry trends
- In terms of revenue, India accounted for 3.2% of the global bioequivalence studies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan bioequivalence studies market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 59.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioequivalence Studies Market Scope
Bioequivalence Studies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Spectris PLC | View profile | 6979 | 44-46 Aldwych, Melbourne House, 5th Floor, London, United Kingdom, WC2B 4LL | https://www.spectris.com |
| Kymos Pharma Services | View profile | 101-250 | Barcelona, Catalonia, Spain, Europe | http://www.kymos.com/ |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
India bioequivalence studies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioequivalence studies market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 60.52% in 2023. Horizon Databook has segmented the India bioequivalence studies market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
- India Bioequivalence Studies Molecule Type Outlook (Revenue, USD Million, 2018-2030)
- Small Molecule
- Large Molecule
- India Bioequivalence Studies Dosage Form Outlook (Revenue, USD Million, 2018-2030)
- Solid Oral Dosage
- Parenteral Formulations
- Topical Products
- Others
- India Bioequivalence Studies Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Hematology
- Immunology
- Neurology
- Metabolic Disorders
- Others
- Oncology
Reasons to subscribe to India bioequivalence studies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India bioequivalence studies market databook
-
Our clientele includes a mix of bioequivalence studies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India bioequivalence studies market, including forecasts for subscribers. This country databook contains high-level insights into India bioequivalence studies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India bioequivalence studies market report size, by molecule type, 2018-2030 (US$M)
India Bioequivalence Studies Market Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
